Patient Reported Outcomes Registry in Patient With Cancer Cachexia

NCT02983500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 253

Last updated 2020-08-07

No results posted yet for this study

Summary

Evaluation of patient reported outcomes (PRO) with tumor cachexia in a real life setting.

Conditions

Sponsors & Collaborators

  • Chugai Pharma Europe Ltd.

    collaborator INDUSTRY
  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Manfred Welslau, MD · Medical practise for oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-28
Primary Completion
2019-07-24
Completion
2019-07-24

Countries

  • Germany

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02983500 on ClinicalTrials.gov